title: Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace.
abstract: BACKGROUND
  The number of people taking prescribed medication for anxiety and depression has increased greatly, but little is known of how this medication impacts on safety at work.
  
  
  OBJECTIVE
  To examine the relation between anxiety and depression, prescribed medication, performance, and safety in the workplace.
  
  
  METHODS
  The research involved nine focus groups with sufferers of anxiety and depression to investigate experiences of mental health problems and the impact of psychotropic drugs. A further three focus groups were conducted with staff in human resources, personnel, occupational health, and health and safety departments, to explore organisational perspectives. The sample comprised 74 individuals drawn from a wide range of occupational sectors. Finally, the results were presented to a panel of experts from occupational medicine, general practice, psychology, health and safety, and psychiatry, to consider the implications for practice.
  
  
  RESULTS
  Workers reported that both the symptoms and the medication impaired work performance. Participants described accidents which they attributed to their condition or to the medication. Workers with responsibilities for others, such as teachers, healthcare workers, and managers appeared to present a particular safety risk. Healthcare workers believed that they placed themselves and their patients at risk when carrying out medical procedures.
  
  
  CONCLUSIONS
  Respondents in this study felt that their symptoms of anxiety and depression and the medication they took to treat these conditions placed them at risk with respect to safety in the workplace. Drawing on the results, the authors outline areas for improvement in the management of mental health problems at work.
authors.affiliation: Institute of Work, Health & Organisations, University of Nottingham, Nottingham Science and Technology Park, Nottingham, UK. cheryl.haslam@nottingham.ac.uk
authors.forename: C
authors.initials: C
authors.lastname: Haslam
authors.forename: S
authors.initials: S
authors.lastname: Atkinson
authors.forename: S
authors.initials: S
authors.lastname: Brown
authors.forename: R A
authors.initials: RA
authors.lastname: Haslam
mesh_terms: D000062:Accidents, Occupational / Q000706:statistics & numerical data; D000063:Accidents, Traffic / Q000706:statistics & numerical data; D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D003866:Depressive Disorder / Q000188:drug therapy*; D004739:England; D005260:Female; D017144:Focus Groups; D006801:Humans; D008297:Male; D008875:Middle Aged; D016272:Occupational Health; D010465:Perception; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012449:Safety; D017132:Workplace / Q000706:statistics & numerical data
chemical_list: D011619:Psychotropic Drugs